St. Louis, MO, United States of America

Walter Smith

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Walter Smith: Innovator in Immune Condition Treatments

Introduction

Walter Smith is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical treatments, particularly focusing on immune conditions. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Walter Smith's latest patents include oral compositions of MK2 pathway inhibitors for the treatment of immune conditions. The present disclosure relates to oral compositions of Compound I or a derivative thereof. Methods of use for treating inflammatory conditions are also disclosed in these patents. This innovative approach aims to provide effective solutions for individuals suffering from various immune-related issues.

Career Highlights

Walter Smith is currently associated with Aclaris Therapeutics, Inc., where he continues to develop groundbreaking treatments. His expertise and dedication to research have positioned him as a key player in the pharmaceutical industry. His work not only showcases his inventive spirit but also highlights the importance of innovation in healthcare.

Collaborations

Walter collaborates with talented professionals in his field, including his coworker Edward Hellriegel. These partnerships enhance the research and development process, leading to more effective treatments for patients.

Conclusion

Walter Smith's contributions to the field of immune condition treatments through his patents and work at Aclaris Therapeutics, Inc. demonstrate his commitment to innovation and improving patient outcomes. His ongoing research is a testament to the importance of advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…